Literature DB >> 21543165

An improved model for predicting radiation pneumonitis incorporating clinical and dosimetric variables.

Peter Jenkins1, Joanne Watts.   

Abstract

PURPOSE: Single dose-volume metrics are of limited value for the prediction of radiation pneumonitis (RP) in day-to-day clinical practice. We investigated whether multiparametric models that incorporate clinical and physiologic factors might have improved accuracy. METHODS AND MATERIALS: The records of 160 patients who received radiation therapy for non-small-cell lung cancer were reviewed. All patients were treated to the same dose and with an identical technique. Dosimetric, pulmonary function, and clinical parameters were analyzed to determine their ability to predict for the subsequent development of RP.
RESULTS: Twenty-seven patients (17%) developed RP. On univariate analysis, the following factors were significantly correlated with the risk of pneumonitis: fractional volume of lung receiving >5-20 Gy, absolute volume of lung spared from receiving >5-15 Gy, mean lung dose, craniocaudal position of the isocenter, transfer coefficient for carbon monoxide (KCOc), total lung capacity, coadministration of angiotensin converting enzyme inhibitors, and coadministration of angiotensin receptor antagonists. By combining the absolute volume of lung spared from receiving >5 Gy with the KCOc, we defined a new parameter termed Transfer Factor Spared from receiving >5 Gy (TFS(5)). The area under the receiver operator characteristic curve for TFS(5) was 0.778, increasing to 0.846 if patients receiving modulators of the renin-angiotensin system were excluded from the analysis. Patients with a TFS(5) <2.17 mmol/min/kPa had a risk of RP of 30% compared with 5% for the group with a TFS(5) ≥ 2.17.
CONCLUSIONS: TFS(5) represents a simple parameter that can be used in routine clinical practice to more accurately segregate patients into high- and low-risk groups for developing RP.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21543165     DOI: 10.1016/j.ijrobp.2010.03.058

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  27 in total

1.  Model development and use of ACE inhibitors for preclinical mitigation of radiation-induced injury to multiple organs.

Authors:  Meetha Medhora; Feng Gao; Qingping Wu; Robert C Molthen; Elizabeth R Jacobs; John E Moulder; Brian L Fish
Journal:  Radiat Res       Date:  2014-10-31       Impact factor: 2.841

2.  Lung texture in serial thoracic CT scans: correlation with radiologist-defined severity of acute changes following radiation therapy.

Authors:  Alexandra R Cunliffe; Samuel G Armato; Christopher Straus; Renuka Malik; Hania A Al-Hallaq
Journal:  Phys Med Biol       Date:  2014-08-26       Impact factor: 3.609

3.  Delayed Effects of Acute Radiation Exposure (Deare) in Juvenile and Old Rats: Mitigation by Lisinopril.

Authors:  Meetha Medhora; Feng Gao; Tracy Gasperetti; Jayashree Narayanan; Abdul Hye Khan; Elizabeth R Jacobs; Brian L Fish
Journal:  Health Phys       Date:  2019-04       Impact factor: 1.316

4.  Dose-volume histogram parameters for predicting radiation pneumonitis using receiver operating characteristic curve.

Authors:  Dongqing Wang; Jian Shi; Shaohua Liang; Shiyong Lu; Xiangjie Qi; Qiang Wang; Guojing Zheng; Sheng Wang; Kemin Zhang; Hongfu Liu
Journal:  Clin Transl Oncol       Date:  2012-09-14       Impact factor: 3.405

5.  Utility of the ACE Inhibitor Captopril in Mitigating Radiation-associated Pulmonary Toxicity in Lung Cancer: Results From NRG Oncology RTOG 0123.

Authors:  William Small; Jennifer L James; Timothy D Moore; Dan J Fintel; Stephen T Lutz; Benjamin Movsas; Mohan Suntharalingam; Yolanda I Garces; Robert Ivker; John Moulder; Stephanie Pugh; Lawrence B Berk
Journal:  Am J Clin Oncol       Date:  2018-04       Impact factor: 2.339

Review 6.  Radiation damage to the lung: mitigation by angiotensin-converting enzyme (ACE) inhibitors.

Authors:  Meetha Medhora; Feng Gao; Elizabeth R Jacobs; John E Moulder
Journal:  Respirology       Date:  2012-01       Impact factor: 6.424

7.  Combined Hydration and Antibiotics with Lisinopril to Mitigate Acute and Delayed High-dose Radiation Injuries to Multiple Organs.

Authors:  Brian L Fish; Feng Gao; Jayashree Narayanan; Carmen Bergom; Elizabeth R Jacobs; Eric P Cohen; John E Moulder; Christie M Orschell; Meetha Medhora
Journal:  Health Phys       Date:  2016-11       Impact factor: 1.316

8.  Do angiotensin-converting enzyme inhibitors reduce the risk of symptomatic radiation pneumonitis in patients with non-small cell lung cancer after definitive radiation therapy? Analysis of a single-institution database.

Authors:  Hongmei Wang; Zhongxing Liao; Yan Zhuang; Ting Xu; Quynh-Nhu Nguyen; Lawrence B Levy; Michael O'Reilly; Kathryn A Gold; Daniel R Gomez
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-10-22       Impact factor: 7.038

Review 9.  2013 Dade W. Moeller lecture: medical countermeasures against radiological terrorism.

Authors:  John E Moulder
Journal:  Health Phys       Date:  2014-08       Impact factor: 1.316

10.  Enalapril mitigates radiation-induced pneumonitis and pulmonary fibrosis if started 35 days after whole-thorax irradiation.

Authors:  Feng Gao; Brian L Fish; John E Moulder; Elizabeth R Jacobs; Meetha Medhora
Journal:  Radiat Res       Date:  2013-10-18       Impact factor: 2.841

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.